LEADER surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers).
about
Potential role of tedizolid phosphate in the treatment of acute bacterial skin infectionsMechanisms of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing.Investigational antimicrobial agents of 2013.Pharmacokinetics of tedizolid following oral administration: single and multiple dose, effect of food, and comparison of two solid forms of the prodrugClinical importance and epidemiology of quinolone resistance.[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].Linezolid surveillance results for the United States: LEADER surveillance program 2011.Linezolid Surveillance Results for the United States (LEADER Surveillance Program 2014).Dissemination of a pSCFS3-like cfr-carrying plasmid in Staphylococcus aureus and Staphylococcus epidermidis clinical isolates recovered from hospitals in Ohio.Association of norB overexpression and fluoroquinolone resistance in clinical isolates of Staphylococcus aureus from Korea.Summary of linezolid activity and resistance mechanisms detected during the 2012 LEADER surveillance program for the United StatesThe emergence of linezolid resistance among Enterococci in intestinal microbiota of treated patients is unrelated to individual pharmacokinetic characteristicsAn evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy.Linezolid: a promising option in the treatment of Gram-positives.Emergence of linezolid-resistant coagulase-negative staphylococci in an intensive care unit.Activities of Tedizolid and Linezolid Determined by the Reference Broth Microdilution Method against 3,032 Gram-Positive Bacterial Isolates Collected in Asia-Pacific, Eastern Europe, and Latin American Countries in 2014.Validation of a commercial dry-form broth microdilution device (Sensititre) for testing tedizolid, a new oxazolidinone.Identification and characterization of linezolid-resistant cfr-positive Staphylococcus aureus USA300 isolates from a New York City medical center.Emergence of mutation-based linezolid-resistant invasive Enterococcus faecalis in a haemodialysis patient in Norway.
P2860
Q26853612-065675FE-41C8-4FAD-BA6B-D35A0F2ECA75Q33648052-B43E9E3D-524A-40B2-BE90-3D1DB96F6CE5Q34375204-73AE37A5-419E-469D-B6D4-67AE0B6FE321Q34548251-B8CE3F14-11AD-4D2E-9594-6B4708416E4AQ34838791-4B576C18-B2DC-4F4E-ABE0-94D186987FF9Q35619094-CE2BBAED-758F-4048-8417-E6CB2737AAA7Q36558466-58322B63-0F8C-4649-ABEB-7CBCBD4B022EQ36730155-65210C8F-AE05-4CB9-9CD5-DE63C4254AF4Q36969913-9EAC658F-83D9-4BE0-863B-2320D9CA5A2DQ37286906-E274AA4F-32C5-4191-BAC8-833A5B52CD32Q37544790-6F16A582-9A37-4F2A-A789-C5544B620D5EQ37712989-A4C20B52-7428-4046-8303-B7E7689D9C95Q38070154-EF686F8C-9C27-43C7-830D-D45D84493494Q39044932-5824CB38-3462-435C-A0CE-665C2AF98B85Q40209052-A1B299AB-C40B-4E04-87E6-7C075C31720EQ40633323-41993D88-25B0-495B-BD98-A8FA0233F290Q41655310-598D8633-E88D-4B5F-8744-722A54E9AC5BQ43045759-DD7FBB63-4500-41ED-8D76-5D1576CCCAAAQ44995073-4422EBDF-42DF-483D-B2E0-42D59C1DCF81
P2860
LEADER surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers).
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
LEADER surveillance program re ...... d States (61 medical centers).
@en
LEADER surveillance program re ...... solates from the United States
@nl
type
label
LEADER surveillance program re ...... d States (61 medical centers).
@en
LEADER surveillance program re ...... solates from the United States
@nl
prefLabel
LEADER surveillance program re ...... d States (61 medical centers).
@en
LEADER surveillance program re ...... solates from the United States
@nl
P2093
P1476
LEADER surveillance program re ...... d States (61 medical centers).
@en
P2093
David J Farrell
James E Ross
Rodrigo E Mendes
Ronald N Jones
P356
10.1016/J.DIAGMICROBIO.2012.05.012
P577
2012-06-15T00:00:00Z